Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Galera Therapeutics (GRTX) just unveiled an announcement.
Galera Therapeutics, Inc. recently settled a lawsuit against two Clinical Research Organizations (CROs) for a sum of $975,000. The dispute centered around a 2021 error in a pivotal Phase 3 cancer trial, which prompted allegations of contract breach and negligence from Galera. With the settlement, both parties have released each other from further obligations and plan to formally conclude the litigation by August 2024.
For detailed information about GRTX stock, go to TipRanks’ Stock Analysis page.